IE
DMII

Israel Englander’s Drugs Made In America Acquisition II Corp DMII Stock Holding History

Israel Englander’s Portfolio DMII Stock Details DMII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.1M Buy
1,993,558
+17,133
+0.9% +$172K 0.01% 1624
2026
Q1 		$19.7M Buy
1,976,425
+476,425
+32% +$4.75M 0.01% 1564
2025
Q4 		$14.8M Buy
+1,500,000
New +$14.8M 0.01% 1855

Other funds holding DMII

KIM
Karpus Investment Management Pittsford, New York $3.48B AUM 10.49% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
TCM
Tenor Capital Management New York $7.09B AUM 3.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Israel Englander's DMII Position: Q2 2026 in Review

Israel Englander increased its Drugs Made In America Acquisition II Corp (DMII) stake by 0.87% in Q2 2026, buying an estimated $172K and bringing the position to 1,993,558 shares worth $20.1M. The position accounts for 0.01% of the portfolio, ranked #1624.

Israel Englander first reported a position in DMII in Q4 2025 and has held it in 3 quarters since. 68 funds tracked by Wall St. Rank hold DMII as of Q2 2026.

  • Israel Englander held 1,993,558 shares of Drugs Made In America Acquisition II Corp worth $20.1M as of Q2 2026.
  • Israel Englander bought 17,133 Drugs Made In America Acquisition II Corp shares in Q2 2026, an estimated $172K.
  • Drugs Made In America Acquisition II Corp made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1624 holding.
  • Israel Englander first reported a position in Drugs Made In America Acquisition II Corp in Q4 2025 and has held it in 3 quarters since.
  • 68 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.